Project Grant R01CA293501
Award Date
5/1/25
Completion Date
4/30/30
Dollars Obligated
$697K
Federal Agency
National Cancer Institute
Federal Grant Program
93.393
Assistance Type
Project Grant
Place of Performance
Massachusetts, USA
Similar Awards
This federal Project Grant award, with the ID K08CA285952, is funded by the National Cancer Institute (NCI) under the Cancer Research Manpower (CFDA 93.398) program. The $197,640 award supports an initiative led by Dr. Adjoa Anyane-Yeboa at the Massachusetts General Hospital (MGH) to develop implementation strategies for increasing colorectal cancer (CRC) screening rates among unscreened individuals aged 45-54, with a focus on racial/ethnic minority populations. The key objectives of this 5-year...
This Project Grant award of $622,913 from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research (CFDA 93.393) program supports research to evaluate a multilevel intervention to increase colonoscopic follow-up after abnormal stool-based colorectal cancer screening in a federally qualified health center (FQHC) setting. The primary objective is to compare the effectiveness of the multilevel intervention versus usual care on receipt of colonoscopy within 6 months of an...
The National Cancer Institute (NCI) awarded a $3,942,082 Cooperative Agreement titled "The Mass Partnership for Community-Engaged Cancer Control Equity" to the Harvard T.H. Chan School of Public Health under the Cancer Cause and Prevention Research (CFDA 93.393) federal grant program. This 5-year award aims to advance cancer control equity by strengthening the capacity of community health centers (CHCs) to deliver evidence-based cancer screening and tobacco treatment services, while...
This federal Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) provides $794,090 to the University of Oklahoma Health Sciences Center to develop and pilot test culturally sensitive digital outreach interventions to increase rates of diagnostic colonoscopy among Native American patients in Oklahoma. The key products/services to be delivered include: 1) Co-developing and integrating a mobile health outreach program (SMS text and videos)...
The federal Project Grant award R01CA282292 for $663,428, provided by the National Cancer Institute under the Cancer Cause and Prevention Research program (CFDA 93.393), supports research to address cancer risk factors and prevention strategies in primary care settings. The project aims to evaluate the comparative effectiveness of two implementation strategy bundles to deliver a web-based intervention called "My Own Health Report" (MOHR) that screens for multiple cancer risks, sets...
This federal Project Grant award for $2,136,715.00, provided by the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research), is focused on "Harnessing DNA Methylation in Peripheral Blood for Improved Colorectal Cancer Prevention". The primary awardee is Harvard College President & Fellows Of, through its Harvard T.H. Chan School of Public Health Division. The project aims to conduct research on utilizing DNA methylation markers in blood samples to enhance...
This $637,596 Project Grant award from the National Cancer Institute (CFDA 93.393 Cancer Cause and Prevention Research program) will fund a research project to test a video-based intervention strategy for reducing defensive colorectal cancer information avoidance and increasing screening uptake. The project aims to reach individuals who tend to avoid colorectal cancer information, as they are less likely to adhere to screening guidelines. The research plan includes a randomized controlled...
The National Cancer Institute (NCI) awarded a Project Grant under the Cancer Cause and Prevention Research (CFDA 93.393) program to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), for the PREDICT (Personalized Risk-Based Follow-Up of Cervical Cancer Screening in Practice) project. The $723,513 award, granted on June 10, 2024, supports the development, testing, and dissemination of a health IT-enabled, multilevel intervention to promote personalized,...
This $269,942 Project Grant from the National Cancer Institute's Cancer Research Manpower program (CFDA 93.398) supports the development and pilot testing of a four-part community health worker (CHW) intervention to improve lung cancer screening uptake and address disparities among Black and Hispanic populations. The key products or services to be delivered under this 5-year award include: 1) jointly "transcreating" the CHW intervention with a community advisory board, 2) conducting...
The National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) awarded a $224,099 Project Grant to the University of California, San Diego (UCSD) to develop a targeted colorectal cancer (CRC) screening strategy for adults ages 45-49. The key objectives are to: 1) characterize the acceptability of CRC screening in this age group and identify factors influencing screening uptake, and 2) conduct a randomized controlled trial to evaluate the comparative effectiveness of an active outreach...